Skip to main content

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’

Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. The company, together with the Veterans Service Team (“VST”), a self-funded, 501(c)(3) non-profit company dedicated to the support and wellness of active duty and former members of all branches of the U.S. military and Coast Guard, today announced that VST has launched public availability of its first collaboration product. The Nano CBD Topical Spray with revolutionary fast performance is enabled by PBIO’s unique, patented UltraShear(TM) nanoemulsions platform technology. Marketed by VST, the product, “Valor CBD,” is inspired by the courage of the men and women who have selflessly served the U.S. “There are few organizations with a mission as honorable as VST’s, supporting veteran’s challenges of pain, PTSD, anxiety, and more, and focused on helping them in multiple ways to succeed and thrive,” said Richard T. Schumacher, PBIO’s president and CEO. “The remarkable performance of the UltraShear Nano-CBD product is closely aligned with that mission (fast-absorbing with reliable payload delivery) to ensure our Vets are getting the best-in-class CBD product on the market, which they so eminently deserve! Our UltraShear Nano-CBD Topical Spray is now available to VST members and non-members alike as ‘Valor CBD’ at, with all profits going to charities supporting veterans and animal welfare.”

To view the full press release, visit

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its products utilize both constant and alternating pressure. The company’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), is used to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly, for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company’s acquisition of the BaroFold(TM) patented technology platform in 2017 allowed it to offer important new bio-pharma contract services and GMP manufacturing equipment to this enormous market sector. Most recently, PBIO developed the commercially scalable and high-efficiency pressure-based Ultra Shear Technology(TM) (UltraShear(TM)) platform, which allows it to produce stable and precisely controlled nanoemulsions of otherwise immiscible oil and water components. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PBIO’s commitment to innovation and cutting-edge technology has established it as the leader in high-pressure platform technologies, providing unique and effective solutions to diverse, major (and growing) global market sectors. For more information about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office

InvestorWire is powered by IBN

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.